The Indian stock market continues to attract fresh listings in 2025, and one of the most talked-about offers is the Fabtech Technologies IPO. Investors are closely tracking this issue because the company operates in a high-growth sector—providing cleanroom solutions and engineering services to industries like pharmaceuticals, biotechnology, and healthcare.
In today’s environment, businesses that enable pharma and biotech infrastructure are in demand, especially with the rising focus on healthcare innovation. This is why Fabtech Technologies’ IPO has generated strong buzz among both retail and institutional investors. But before making any investment decision, it’s important to carefully analyze its IPO dates, price band, lot size, financial performance, Grey Market Premium (GMP), and overall risk factors.
This article provides you with a complete breakdown of Fabtech Technologies IPO, so you can decide if it deserves a spot in your portfolio.
Fabtech Technologies IPO Overview
Here are the most important details about the IPO in one glance:
| Particulars | Details |
|---|---|
| IPO Opening Date | September 29, 2025 |
| IPO Closing Date | October 1, 2025 |
| Price Band | ₹181 – ₹191 per share |
| Face Value | ₹10 per share |
| Issue Size | Approx ₹230.35 crore (Fresh Issue only) |
| Lot Size | 75 shares |
| Retail Quota | 35% |
| QIB Quota | 50% |
| HNI/NII Quota | 15% |
| Allotment Date | October 3, 2025 |
| Listing Date (Tentative) | October 7, 2025 |
| Promoters | Aasif Ahsan Khan, Hemant Mohan Anavkar, Aarif Ahsan Khan, Manisha Hemant Anavkar |
This structured issue gives retail investors a good opportunity to participate, with a balanced quota for institutions and high-net-worth individuals.
Fabtech Technologies IPO GMP (Grey Market Premium)
The Grey Market Premium, or GMP, reflects investor sentiment in the unofficial market before listing. Currently, the Fabtech Technologies IPO GMP has 35-40 { 18-20%}. Since GMP usually picks up closer to the listing date, investors should track it daily if they plan short-term listing gains.
It’s important to remember that GMP is highly speculative and does not always guarantee listing performance. Investors should use GMP as a reference but not the sole factor in making investment decisions.
Fabtech Technologies Financial Performance
The company has shown consistent growth in revenue and profitability over the last few years. Let’s look at the financial highlights:
| Financial Year | Revenue (₹ Cr) | Net Profit (₹ Cr) | Profit Margin |
|---|---|---|---|
| FY 2023 | ~193.8 | ~21.7 | 11.2% |
| FY 2024 | ~226.1 | ~27.2 | 12.0% |
| FY 2025 (Estimated) | ~326.6 | ~46.4 | 14.2% |
Key Takeaways:
-
The company has shown steady revenue growth year-on-year.
-
Profit margins have also improved, indicating operational efficiency.
-
Debt levels are under control, making the company’s balance sheet stronger.
Valuation and Ratios
Based on the IPO price band, the company’s Price to Earnings (P/E) ratio is estimated to be in a reasonable range compared to industry peers. With earnings per share (EPS) of approximately ₹8.4 (FY 2024), the valuation seems fair, though investors should wait for listing day sentiment to confirm market appetite.
Return on Equity (ROE) and Return on Capital Employed (ROCE) also look encouraging, which may attract institutional interest.
Strengths of Fabtech Technologies
-
Strong Industry Demand: Operates in pharma and biotech infrastructure, which has long-term growth potential.
-
Healthy Financials: Consistent revenue growth with improving profit margins.
-
Experienced Promoters: Founders have decades of experience in cleanroom technology.
-
Balanced IPO Structure: Allocation for QIB, HNI, and retail ensures wide participation.
Risks and Concerns
While the IPO looks attractive, investors should be cautious about a few points:
-
Sector Dependency: The company relies heavily on pharma and biotech sectors; any slowdown could impact revenues.
-
Execution Risk: Large projects in cleanroom solutions require timely execution. Delays can affect profitability.
-
Valuation Risk: If the stock lists at a stretched valuation, there could be post-listing corrections.
-
Market Volatility: Broader market movements will directly affect listing day performance.
Also read:-
Should You Invest in Fabtech Technologies IPO?
If you are a long-term investor, Fabtech Technologies IPO offers a chance to participate in a business that aligns with the growth of India’s pharmaceutical and healthcare infrastructure. The company’s strong order book and improving margins make it attractive for fundamental investors.
For short-term traders, the listing gains will depend on how the GMP evolves in the coming days. Since the GMP is yet to start, it is better to monitor demand closer to the allotment and listing dates.
Overall, Fabtech Technologies IPO looks like a balanced opportunity with growth potential, but it should be evaluated based on individual risk appetite.
Conclusion
The Fabtech Technologies IPO 2025 comes at a time when the healthcare and pharma sectors are seeing strong investment. With improving financials and sector-wide demand, the company looks fundamentally strong. However, investors should balance optimism with caution, especially regarding GMP speculation and market volatility.
This IPO can be a good addition for long-term investors seeking exposure to niche engineering and cleanroom infrastructure, while traders can look for potential listing gains if sentiment remains strong.
FAQs on Fabtech Technologies IPO 2025
1. What is Fabtech Technologies IPO GMP today?
Currently, the Fabtech Technologies IPO GMP (Grey Market Premium) has not started yet. Investors should track daily updates closer to the listing date for accurate GMP trends.
2. What is the Fabtech Technologies IPO opening and closing date?
The IPO will open on September 29, 2025, and close on October 1, 2025.
3. What is the Fabtech Technologies IPO price band?
The IPO price band has been fixed between ₹181 and ₹191 per share.
4. What is the lot size for Fabtech Technologies IPO?
Retail investors can apply with a minimum lot size of 75 shares.
5. What is the issue size of Fabtech Technologies IPO?
The total issue size is approximately ₹230.35 crore, and it is a complete Fresh Issue.
6. When is the Fabtech Technologies IPO allotment date?
The basis of allotment will be finalized on October 3, 2025.
7. When will Fabtech Technologies IPO shares list on the stock exchange?
The tentative listing date is October 7, 2025, on both NSE and BSE.
8. Who are the promoters of Fabtech Technologies?
The promoters are Aasif Ahsan Khan, Hemant Mohan Anavkar, Aarif Ahsan Khan, and Manisha Hemant Anavkar.
9. Should you invest in Fabtech Technologies IPO for listing gains?
Listing gains will depend on market sentiment and GMP closer to the listing date. Investors with a short-term outlook should monitor GMP trends, while long-term investors can focus on the company’s financial growth.
10. Is Fabtech Technologies IPO good for long-term investment?
Fabtech operates in the cleanroom and pharma infrastructure sector, which has strong growth potential. With steady revenue and profit growth, it may be attractive for long-term investors. However, risks like sector dependency and execution challenges must be considered.